465 related articles for article (PubMed ID: 21946514)
1. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis.
Hung WT; Chen YM; Lan JL; Chen HH; Chen YH; Chen DY; Hsieh CW; Wen MC
Lupus; 2011 Nov; 20(13):1404-10. PubMed ID: 21946514
[TBL] [Abstract][Full Text] [Related]
2. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
[TBL] [Abstract][Full Text] [Related]
3. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
[TBL] [Abstract][Full Text] [Related]
4. Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients.
Saisoong S; Eiam-Ong S; Hanvivatvong O
Clin Exp Rheumatol; 2006; 24(1):51-8. PubMed ID: 16539819
[TBL] [Abstract][Full Text] [Related]
5. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers.
Akhter E; Burlingame RW; Seaman AL; Magder L; Petri M
Lupus; 2011 Oct; 20(12):1267-74. PubMed ID: 21813587
[TBL] [Abstract][Full Text] [Related]
6. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
7. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus.
Ng KP; Manson JJ; Rahman A; Isenberg DA
Arthritis Rheum; 2006 Dec; 55(6):900-4. PubMed ID: 17139667
[TBL] [Abstract][Full Text] [Related]
8. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
Pradhan VD; Patwardhan MM; Ghosh K
Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
[TBL] [Abstract][Full Text] [Related]
9. Antinucleosome antibodies and systemic lupus erythematosus.
Düzgün N; Sahin M; Genç Y; Tutkak H
Ann N Y Acad Sci; 2007 Aug; 1109():421-8. PubMed ID: 17785331
[TBL] [Abstract][Full Text] [Related]
10. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
Mok CC; Ho LY; Leung HW; Wong LG
Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of chromatin fragments are inversely correlated with anti-dsDNA antibody levels in human and murine systemic lupus erythematosus.
Jørgensen MH; Rekvig OP; Jacobsen RS; Jacobsen S; Fenton KA
Immunol Lett; 2011 Aug; 138(2):179-86. PubMed ID: 21530588
[TBL] [Abstract][Full Text] [Related]
12. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
Ezzat M; El-Gammasy T; Shaheen K; Shokr E
Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
[TBL] [Abstract][Full Text] [Related]
14. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
[TBL] [Abstract][Full Text] [Related]
15. Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis.
Alzawawy A; Zohary M; Ablordiny M; Eldalie M
Int J Rheum Dis; 2009 Dec; 12(4):311-8. PubMed ID: 20374368
[TBL] [Abstract][Full Text] [Related]
16. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis.
Moroni G; Radice A; Giammarresi G; Quaglini S; Gallelli B; Leoni A; Li Vecchi M; Messa P; Sinico RA
Ann Rheum Dis; 2009 Feb; 68(2):234-7. PubMed ID: 18718989
[TBL] [Abstract][Full Text] [Related]
17. [Serological and histological study of lupus nephritis with special reference to anti-SSA antibody].
Nakashima A
Nihon Jinzo Gakkai Shi; 1989 Jul; 31(7):743-55. PubMed ID: 2585828
[TBL] [Abstract][Full Text] [Related]
18. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC; Zhou B; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
[TBL] [Abstract][Full Text] [Related]
19. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
[TBL] [Abstract][Full Text] [Related]
20. Analysis of immunity index and immunopathogenesis pattern of lupus nephritis patients.
Gao JX; Diao HL; Liu YQ; Lv M; Dong H; Zhang XM; Wang YN
J Biol Regul Homeost Agents; 2015; 29(1):201-6. PubMed ID: 25864759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
